News & Insights
Sort By
Client News 16 Results
Client News
|January 15, 2025
Colossal Biosciences Announces $200M Series C and $10.2B Valuation
The world’s first de-extinction company, Colossal Biosciences, announces its $200 million Series C financing led by TWG Global
Client News
|September 9, 2024
17th Annual Venture Atlanta Conference Showcases Gunderson Dettmer Clients
Venture Atlanta showcases 5 Gunderson Dettmer company clients at the 17thannual Venture Atlanta Conference, one of the nation's largest and most prestigious venture capital conferences
Client News
|September 9, 2024
Vignette Bio Announces its Merger with Candid Therapeutics
Foresite Labs incubated company, Vignette Bio, announces its acquisition by Candid Therapeutics, an innovative biotechnology company developing T-cell engager (“TCE”) antibodies
Firm News 1 result
Firm News
|January 7, 2015
Gunderson Dettmer Announces New Partners
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP has announced the election of seven new partners from within the firm, both based in the firm’s Boston office, effective January 1, 2014.